10-K: CareView Communications Reports Increased Losses in 2024 Amid Revenue Decline

CareView Communications' 2024 10-K filing reveals a net loss of $4.7 million, a decrease in revenue, and substantial doubt about the company's ability to continue as a going concern.

Summary

• CareView Communications' 10-K filing for the year ended December 31, 2024, indicates a challenging financial year.
• The company experienced a decrease in revenue from $9.68 million in 2023 to $8.25 million in 2024.
• The net loss increased from $3.95 million in 2023 to $4.70 million in 2024.
• The company's operating loss also increased from $688,000 in 2023 to $1.58 million in 2024.
• The filing expresses substantial doubt about CareView's ability to continue as a going concern due to net losses, cash outflows, and a working capital deficit of $41.14 million.
• Management plans to address these concerns through increased sales, cost control, and potential capital raising activities.
• The company's backlog as of December 31, 2024, for sales-based contracts is approximately $5.93 million, with $3.31 million expected to be billed during 2025.
• The monthly billable amount for subscription-based contracts as of December 31, 2024, is approximately $296,500 under contract and $50,300 month to month.
• CareView employed 62 people on a full-time basis as of March 31, 2025.
• The company extended its credit agreement with PDL BioPharma, Inc. to June 30, 2025.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to increased losses, decreased revenue, and concerns about the company's ability to continue as a going concern. While management is taking steps to address these issues, the overall sentiment is pessimistic.

Positives

• The company has a sales-based contract backlog of approximately $5.93 million as of December 31, 2024.
• Management is actively pursuing strategies to improve the company's financial position, including increasing sales and controlling costs.
• The company has extended its credit agreement with PDL BioPharma, Inc. to June 30, 2025, providing additional time to address its financial challenges.
• The company is working with HealthTrust and Premier on new contracts.

Negatives

• The company experienced a decrease in revenue from $9.68 million in 2023 to $8.25 million in 2024.
• The net loss increased from $3.95 million in 2023 to $4.70 million in 2024.
• The company's operating loss also increased from $688,000 in 2023 to $1.58 million in 2024.
• The filing expresses substantial doubt about CareView's ability to continue as a going concern due to net losses, cash outflows, and a working capital deficit of $41.14 million.

Risks

• The company's ability to continue as a going concern is uncertain due to its financial condition.
• The company is dependent on obtaining adequate financing to fulfill its growth and operating activities.
• The company is subject to risks associated with research, development, and successful testing of its products.
• The company is susceptible to infringement on the proprietary rights of others.
• The company's success depends on its ability to maintain and enhance the performance, content, and reliability of its products.
• The company's revenue is concentrated among a few major customers.

Future Outlook

The company's future outlook is uncertain, with management focusing on increasing sales, controlling costs, and potentially raising additional capital to address its financial challenges.

Management Comments

• Management has evaluated the significance of the conditions described above in relation to the Company's ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the consolidated financial statements were issued.
• While management will look to continue funding operations by increased sales volumes and raising additional capital from sources such as sales of its debt or equity securities or loans to meet operating cash requirements, there is no assurance that managements plans will be successful.

Industry Context

CareView operates in the healthcare technology sector, providing patient video monitoring solutions. The company faces competition from other clinical video monitoring providers and alternative fall prevention mechanisms. The increasing demand for remote patient monitoring, driven by staffing shortages and the need for efficient care delivery, presents an opportunity for CareView's solutions.

Comparison to Industry Standards

• CareView competes with companies like Cisco Systems, Avasure, Caregility, Royal Philips Electronics, and Cerner Corporation in the clinical video monitoring market.
• Unlike some competitors that offer rolling camera stands, CareView emphasizes its patented Virtual Bed Rails and Virtual Chair Rails technology.
• CareView's success is measured by its ability to provide significant cost savings, reduce patient falls, and improve patient care documentation, aligning with industry goals for enhanced patient safety and operational efficiency.

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment due to the company's financial challenges.
• Employees face uncertainty regarding job security due to the company's going concern status.
• Customers may be concerned about the company's ability to provide ongoing support and services.
• Creditors face increased risk of non-payment due to the company's financial difficulties.

Next Steps

• Management plans to continue funding operations by increasing sales volumes.
• Management plans to continue funding operations by raising additional capital from sources such as sales of its debt or equity securities or loans to meet operating cash requirements.
• Management continues to monitor the immediate and future cash flows needs of the company in a variety of ways which include forecasted net cash flows from operations, capital expenditure control, new inventory orders, debt modifications, increases sales outreach, streamlining and controlling general and administrative costs, competitive industry pricing, sale of equities, debt conversions, new product or services offerings, and new business partnerships.

Key Dates

Keywords

CareView Communications, patient safety system, video monitoring, financial results, going concern, revenue, net loss, 10-K, healthcare, contracts